Global Adipose Tissue Derived Stem Cells (ADSCS) Market, By Cell Line (Human Adipose Tissue-Derived Stem Cells, Rat Adipose Tissue-Derived Stem Cells), Reagents (Media, Sera, Kits), Application (Regenerative Medicine, Tissue Engineering, Cell Therapy, Others), End User (Biotechnology Companies, Academic and Research Institutes) – Industry Trends and Forecast to 2029.
Adipose Tissue Derived Stem Cells (ADSCS) Market Analysis and Size
Adult stem cells, which are generated from adipose tissue, have excellent potential for regenerative therapy. The adipose tissue-derived stem cells exhibit higher yields than other stem cell sources. Skin, bone, and cartilage regeneration are a few of the regenerative medicine used for stem cells produced from adipose tissue.
Data Bridge Market Research analyses that the adipose tissue derived stem cells (ADSCS) market is expected to undergo a CAGR of 6.60% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Adipose Tissue Derived Stem Cells (ADSCS) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Cell Line (Human Adipose Tissue-Derived Stem Cells, Rat Adipose Tissue-Derived Stem Cells), Reagents (Media, Sera, Kits), Application (Regenerative Medicine, Tissue Engineering, Cell Therapy, Others), End User (Biotechnology Companies, Academic and Research Institutes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Lonza (U.S.), ThermoFisher Scientific Inc. (U.S.), Celprogen, Inc (U.S.), iXCells Biotechnologies (U.S.), Merck KGaA (Germany), Lifeline Cell Technology (U.S.), AlloCure, Inc. (U.S.), Antria, Inc. (U.S.), Celgene Corporation (U.S.), Cellleris SA (Spain), Corestem, Inc. (South Korea), Cytori Therapeutics, Inc. (U.S.), Intrexon, Inc. (U.S.), Mesoblast Ltd. (Australia), Pluristem Therapeutics, Inc. (Israel), and Tissue Genesis (U.S.)
|
|
Market Opportunities
|
|
Market Definition
The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.
Adipose Tissue Derived Stem Cells (ADSCS) Market Dynamics
Drivers
- Increased potential demand from the cartilage
The market for adipose tissue-derived stem cells is expanding due to the development of stem cell-based research for efficient drug manufacture and expansion in biotech applied sciences (ADSCS). When compared to other alternative stem cells such bone marrow the approach used is far more productive. The adipose tissue-derived stem cells (ADSCS) market is anticipated to have increased potential demand from the cartilage and bone regeneration industry.
- Utilisation of reagents to provide successful results
The utilisation of reagents to provide successful results for the stem cell business will drive market expansion. Reagent kits are used in the cell line experiments performed on humans and rats. Adipose tissue-derived stem cells (ADSCS) market growth is predicted to occur between 2022 and 2029 due to a number of causes.
Opportunities
Additionally, a rise in regulatory approvals for adipose derived stem cell targeted clinical trials globally, a rise in private and public funding for stem cell-based research, and a surge in partnerships and collaborations for the development of advanced stem cell line manufacturing technologies are all contributing to the market growth for adipose tissue derived stem cells.
Restraints/Challenges
Moral objections and stringent guidelines for handling experiments may serve as market restraints during a period of market expansion. Adipose tissue-derived stem cells (ADSCS) are ineffective at distinguishing between the tissues and organs of the human body, which could impede the market's expansion.
This adipose tissue derived stem cells (ADSCS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adipose tissue derived stem cells (ADSCS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Adipose Tissue Derived Stem Cells (ADSCS) Market Scope
The adipose tissue derived stem cells (ADSCS) market is segmented on the basis of cell line, reagents, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Cell Line
- Human Adipose Tissue-Derived Stem Cells
- Rat Adipose Tissue-Derived Stem Cells
Reagents
- Media
- Sera
- Kits
Application
- Regenerative Medicine
- Tissue Engineering
- Cell Therapy
- Others
End User
- Biotechnology Companies
- Academic
- Research Institutes
Adipose Tissue Derived Stem Cells (ADSCS) Market Regional Analysis/Insights
The adipose tissue derived stem cells (ADSCS) market is analysed and market size insights and trends are provided by country, cell line, reagents, application and end user as referenced above.
The countries covered in the adipose tissue derived stem cells (ADSCS) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the adipose tissue-derived stem cells (ADSCS) market due to the amplified research and development of stem cells and tissue engineering.
Asia-Pacific (APAC) is expected to cater potential market base for adipose tissue-derived stem cells (ADSCS) due to government support in China.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Adipose Tissue Derived Stem Cells (ADSCS) Market Share Analysis
The adipose tissue derived stem cells (ADSCS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to adipose tissue derived stem cells (ADSCS) market.
Some of the major players operating in the adipose tissue derived stem cells (ADSCS) market are:
- Lonza (U.S.)
- ThermoFisher Scientific Inc. (U.S.)
- Celprogen, Inc (U.S.)
- iXCells Biotechnologies (U.S.)
- Merck KGaA (Germany)
- Lifeline Cell Technology (U.S.)
- AlloCure, Inc. (U.S.)
- Antria, Inc. (U.S.)
- Celgene Corporation (U.S.)
- Cellleris SA (Spain)
- Corestem, Inc. (South Korea)
- Cytori Therapeutics, Inc. (U.S.)
- Intrexon, Inc. (U.S.)
- Mesoblast Ltd. (Australia)
- Pluristem Therapeutics, Inc. (Israel)
- Tissue Genesis (U.S.)
SKU-